(Q48036673)

English

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.

scientific article published in March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

1 reference

based on heuristic

inferred from title

Stephen L. Hoffman

7

object named as

Hoffman SL

1 reference

Europe PubMed Central

7 February 2018

Alessandro Sette

12

object named as

Sette A

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

author name string

del Guercio MF

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Alexander J

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Kubo RT

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Arrhenius T

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Maewal A

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Appella E

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Jones T

8

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Valmori D

9

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Sakaguchi K

10

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Grey HM

11

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

15

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

441-448

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epitope selection and development of peptide based vaccines to treat cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying strategies for immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal transduction by the B cell antigen receptor and its coreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of human B-cell activation and adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomes containing lipid A as a potent non-toxic adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic peptide vaccine confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for the development of an engineered sporozoite malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of priming with carrier on response to conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of Prior Vaccinations for the Development of New Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900186-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(97)00186-2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9141216

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48036673&oldid=1539332456"